Imm -529 hasn’t got to the trial registration stage, they are still in pre trial meetings with fda, so is not listed on clinical trials.gov. Immuron hopes to start the trial in 2025
I believe the USU Travelan trial is not an official trial approved by the FDA so not registered on clinical trials.gov. I don’t think there’s been any results published on the trial. But there has been some updates provided by Immuron on the trial status and protocol. There may be info on the trial at USU.
In any case, results are due 1st qtr 25 according to Immuron’s latest presentation. It is a large trial so it should have market value.
- Forums
- ASX - By Stock
- IMC
- Clinical Programs
Clinical Programs, page-2
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
-0.001(1.37%) |
Mkt cap ! $16.49M |
Open | High | Low | Value | Volume |
7.2¢ | 7.2¢ | 7.2¢ | $3.325K | 46.17K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 114000 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 217134 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 114000 | 0.073 |
2 | 78708 | 0.072 |
1 | 7068 | 0.071 |
1 | 30000 | 0.070 |
1 | 11594 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 217134 | 4 |
0.084 | 80000 | 1 |
0.085 | 24038 | 1 |
0.086 | 147746 | 1 |
0.099 | 1300 | 1 |
Last trade - 10.56am 12/11/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online